Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bicycle Therapeutics Limited

8.77
+0.03500.40%
Volume:535.15K
Turnover:4.81M
Market Cap:606.56M
PE:-3.02
High:9.50
Open:9.00
Low:8.72
Close:8.73
Loading ...

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
22 Apr

Bicycle Therapeutics Price Target Maintained With a $30.00/Share by Needham

Dow Jones
·
09 Apr

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

Bicycle Therapeutics Names Felix J. Baker as Chairman

MT Newswires Live
·
27 Mar

BRIEF-Bicycle Therapeutics PLC Felix J. Baker To Become Chairman Of Board Of Directors

Reuters
·
27 Mar

Bicycle names Pierre Legault chairman, Eric Westin chief medical officer

TIPRANKS
·
27 Mar

Bicycle Therapeutics Plc: Felix J. Baker to Become Chairman of Board of Directors

THOMSON REUTERS
·
27 Mar

Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments

Business Wire
·
27 Mar

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading

MT Newswires Live
·
17 Mar

Bicycle Therapeutics Price Target Maintained With a $30.00/Share by Needham

Dow Jones
·
11 Mar

European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading

MT Newswires Live
·
04 Mar

BRIEF-Eckert & Ziegler Enters Partnership With Bicycle Therapeutics

Reuters
·
27 Feb

Stock Track | Bicycle Therapeutics Surges 5.23% After Narrower FY 2024 Loss, Strong Revenue Growth

Stock Track
·
26 Feb

Barclays Remains a Buy on Bicycle Therapeutics (BCYC)

TIPRANKS
·
26 Feb

Bicycle Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
26 Feb

Bicycle Therapeutics Plc : Jefferies Cuts Target Price to $42 From $53

THOMSON REUTERS
·
26 Feb

TD Cowen Keeps Their Buy Rating on Bicycle Therapeutics (BCYC)

TIPRANKS
·
26 Feb

Bicycle Therapeutics PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
25 Feb

Bicycle Therapeutics Q4 2024 GAAP EPS $(0.75) Beats $(0.87) Estimate, Cash And Cash Equivalents Of $879.5M As Of December 31, 2024, Expected To Provide Financial Runway Into 2H 2027

Benzinga
·
25 Feb

Bicycle Therapeutics Q4 Operating Incom USD -67.663 Million

THOMSON REUTERS
·
25 Feb